Home/Pipeline/Undisclosed Collaborative Program 1

Undisclosed Collaborative Program 1

Undisclosed

ClinicalActive

Key Facts

Indication
Undisclosed
Phase
Clinical
Status
Active
Company

About D.E. Shaw Research

D.E. Shaw Research is a private, computationally-driven drug discovery company that operates at the intersection of supercomputing, molecular dynamics, and machine learning. The company has built a unique, fully integrated platform combining proprietary hardware (Anton supercomputers) and software to simulate biological processes with unprecedented timescales and resolution. This enables the atomic-level design of novel therapeutics, resulting in a pipeline with seven clinical-stage drug candidates, three of which were designed independently. The company represents a highly specialized and capital-intensive approach to de-risking early-stage drug discovery through physics-based simulation.

View full company profile

Other Undisclosed Drugs

DrugCompanyPhase
Preclinical ISAC 1Bolt BiotherapeuticsPreclinical
Preclinical ISAC 2Bolt BiotherapeuticsPreclinical
ART12.11Artelo BiosciencesPreclinical
Novel VaccinesMSDDevelopment
SLS-009Seelos TherapeuticsDiscovery
Technosphere Platform (New Formulations)MannKindDiscovery/Preclinical
Measovir®-based Prophylactic Vaccine (with Unither)OncovitaResearch/Pre-clinical
Internal sdAb Discovery ProgramNanoTag BiotechnologiesDiscovery
NB-701Nerai BiosciencesDiscovery
Undisclosed Therapeutic Program(s)Bright CellClinical Trial (Phase unspecified)
Biosimilars PipelineIntelligent TherapeuticsPre-clinical/Development
Proprietary Therapeutic PipelineExcelsior SciencesDiscovery